Ninety One North America’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-33,276
Closed -$1.53M 69
2023
Q4
$1.53M Sell
33,276
-70
-0.2% -$2.98K 0.07% 66
2023
Q3
$1.43M Sell
33,346
-144,250
-81% -$6.73M 0.07% 64
2023
Q2
$8.48M Buy
177,596
+75,567
+74% +$3.64M 0.36% 36
2023
Q1
$4.97M Sell
102,029
-12,608
-11% -$642K 0.23% 53
2022
Q4
$6.06M Sell
114,637
-79,400
-41% -$3.91M 0.3% 37
2022
Q3
$8.49M Buy
194,037
+1,730
+0.9% +$85.5K 0.41% 32
2022
Q2
$9.63M Buy
192,307
+20,578
+12% +$1M 0.43% 31
2022
Q1
$8.92M Buy
171,729
+2,868
+2% +$148K 0.33% 49
2021
Q4
$9.95M Buy
168,861
+31,859
+23% +$1.83M 0.35% 52
2021
Q3
$7.51M Hold
137,002
0.35% 53
2021
Q2
$7.03M Buy
137,002
+10,590
+8% +$547K 0.33% 57
2021
Q1
$6.53M Buy
126,412
+16,758
+15% +$921K 0.38% 54
2020
Q4
$6.14M Buy
+109,654
New +$5.85M 0.38% 59

Other funds holding QGEN

Ninety One North America's QGEN Position: Q1 2024 in Review

Ninety One North America sold out of Qiagen (QGEN) in Q1 2024, closing a stake of 33,276 shares — an estimated $1.53M sold.

Ninety One North America first reported a position in QGEN in Q4 2020 and held it in 13 quarters. The position peaked at $9.95M in Q4 2021. 282 funds tracked by Wall St. Rank hold QGEN as of Q1 2024.

  • Ninety One North America reported no remaining Qiagen position as of Q1 2024 after selling out during the quarter.
  • Ninety One North America sold 33,276 Qiagen shares in Q1 2024, an estimated $1.53M.
  • Ninety One North America first reported a position in Qiagen in Q4 2020 and held it in 13 quarters.
  • Ninety One North America's Qiagen position peaked at $9.95M in Q4 2021.
  • 282 funds tracked by Wall St. Rank held Qiagen as of Q1 2024.

Based on Ninety One North America's 13F filing for Q1 2024, filed 25 Apr 2024.